Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001738995-21-000002
Filing Date
2021-12-17
Accepted
2021-12-16 19:22:11
Documents
1
Effectiveness Date
2021-12-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9426
  Complete submission text file 0001738995-21-000002.txt   10481
Mailing Address 1928 OLD MIDDLEFIELD WAY, SUITE B MOUNTAIN VIEW CA 94043
Business Address 1928 OLD MIDDLEFIELD WAY, SUITE B MOUNTAIN VIEW CA 94043 650-248-7914
Tulavi Therapeutics, Inc. (Filer) CIK: 0001738995 (see all company filings)

EIN.: 824929716 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-425477 | Film No.: 211499165